[Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment].
Palacios Muñoz
R
R
Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Málaga.
Santos González
J
J
Bosch García
R
R
Márquez Solero
M
M
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D018119:Stavudine / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000473:pathology
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D018119:Stavudine; D016049:Didanosine
Exantema en un paciente infectado por el virus de la inmunodeficiencia humana tras iniciar tratamiento antirretrovírico.